Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma

Tyce J. Kearl, Weiqing Jing, Jill A. Gershan, Bryon D. Johnson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology